<unk>  (trade name Veraflox) is a 3rd generation enhanced spectrum veterinary antibiotic of the fluoroquinolone class. It was developed by Bayer HealthCare AG, Animal Health GmbH, and received approval from the European Commission in April 2011 for prescription-only use in veterinary medicine for the treatment of bacterial infections in dogs and cats.
Pradofloxacin
Balofloxacin
Difloxacin
Delafloxacin
Telithromycin
Gemifloxacin
Marbofloxacin
Azithromycin 